West Pharmaceutical Services (WST) Research & Development (2016 - 2025)
Historic Research & Development for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $21.8 million.
- West Pharmaceutical Services' Research & Development rose 1783.78% to $21.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $74.3 million, marking a year-over-year increase of 752.53%. This contributed to the annual value of $74.3 million for FY2025, which is 752.53% up from last year.
- According to the latest figures from Q4 2025, West Pharmaceutical Services' Research & Development is $21.8 million, which was up 1783.78% from $17.1 million recorded in Q3 2025.
- West Pharmaceutical Services' Research & Development's 5-year high stood at $21.8 million during Q4 2025, with a 5-year trough of $12.2 million in Q1 2021.
- Moreover, its 5-year median value for Research & Development was $16.3 million (2023), whereas its average is $16.2 million.
- As far as peak fluctuations go, West Pharmaceutical Services' Research & Development skyrocketed by 2777.78% in 2021, and later crashed by 738.64% in 2025.
- Over the past 5 years, West Pharmaceutical Services' Research & Development (Quarter) stood at $13.7 million in 2021, then grew by 16.06% to $15.9 million in 2022, then increased by 15.72% to $18.4 million in 2023, then increased by 0.54% to $18.5 million in 2024, then grew by 17.84% to $21.8 million in 2025.
- Its Research & Development was $21.8 million in Q4 2025, compared to $17.1 million in Q3 2025 and $19.1 million in Q2 2025.